Results 271 to 280 of about 53,623 (345)

Recent Applications and Prospects of Enzymes in Quality and Safety Control of Fermented Foods. [PDF]

Foods
Dai Y, Chen Y, Lin X, Zhang S.
europepmc   +1 more source

On the Chemical Nature of Taka-amylase. IV

, 1940
Shiro Akabori, Shigeya HAYASHI, Katuhiko KASIMOTO   +2 more
openalex   +2 more sources

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ENCORE Study)

International Journal of Urology, EarlyView.
ABSTRACT Objectives Combination therapy of nivolumab‐plus‐ipilimumab has been approved for advanced or metastatic renal cell carcinoma in Japan, but large‐scale clinical data targeting Japanese patients is limited. To evaluate the early outcomes and factors related to early progression and response.
Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka, Shuzo Hamamoto, Masahiro Nozawa, Kazuyuki Numakura, Atsushi Mizokami, Tsunenori Kondo, Sei Naito, Takashige Abe, Kojiro Ohba, Masayoshi Nagata, Shunta Onodera, Hiroaki Ito, Hirotsugu Uemura   +14 more
wiley   +1 more source

Origin of Amylase in Dogs

Gastroenterology, 1972
openaire   +3 more sources

Can Physicochemical Properties Alter the Potency of Aeroallergens? Part 2 - Impact of Physicochemical Properties. [PDF]

Curr Allergy Asthma Rep
Teixeira CSS, Carriço-Sá B, Villa C, Mafra I, Costa J.   +4 more
europepmc   +1 more source

Die Abhängigkeit der Enzymentwicklung, insbesondere von Amylase und Protease, von der Art der Gerste und ihrer Keimung

, 1940
H. Nakamura
openalex   +2 more sources

Switching PD‐1 to BRAF + MEK inhibition improves recurrence‐free survival in patients receiving a second course of adjuvant melanoma therapy

Journal of the European Academy of Dermatology and Venereology, EarlyView.
66 patients from 22 centers received adjuvant treatment after relapse under or after previous adjuvant therapy with BRAF + MEK or PD‐1. Data highlight a significant benefit when switching from PD‐1 to BRAF + MEK adjuvant therapy compared to a switch from BRAF + MEK to PD‐1 adjuvant regimens.
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, Carmen Loquai, Ulrike Schultheis, Sevil Börger, Alexander Thiem, Steffen Emmert, Magdalena Hoellwerth, Peter Kölblinger, Van Anh Nguyen, Marina Wanner, Erika Richtig, Wiebke K. Peitsch, Wolfgang Harth, Veronika Zenderowski, Andreas Dominik Braun, Miriam Mengoni, Reinhard Dummer, Johanna Mangana, Lara Valeska Maul, Frank Meis, Klemens Rappersberger, Oana Diana Persa, Tilo Biedermann, Christian Posch   +25 more
wiley   +1 more source

Coeliac disease masquerading as macroamylasaemia. [PDF]

BMJ Case Rep
Al-Rufayi B, Alsabban AM, Zagnoon AA.
europepmc   +1 more source

A NOTE ON THE PREPARATION OF STARCH SUBSTRATES FOR AMYLASE DETERMINATIONS

, 1935
William R. Thompson
openalex   +1 more source

The Pathology and Blood Biochemistry of Juvenile Lates calcarifer on Diets Contaminated With Mycotoxins, Histamines and Rancid Fats—A Case Study

Journal of Fish Diseases, EarlyView.
ABSTRACT Mycotoxins, originating from contaminated raw materials or suboptimal feed storage, are a growing concern in tropical aquaculture. Common fungi such as Aspergillus spp. and Fusarium spp. produce mycotoxins including aflatoxin, fumonisin, deoxynivalenol and zearalenone. High doses or prolonged exposure (weeks) to low doses of these mycotoxins (<
Aidan Kwok, Jose A. Domingos, Joseph Oh, Piero Chan, Joyce J. L. Ong, Leo Nankervis, Jeffrey Ling, Robert Nichol, Susan Gibson‐Kueh   +8 more
wiley   +1 more source